Literature DB >> 8387891

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

D W Banner1, A D'Arcy, W Janes, R Gentz, H J Schoenfeld, C Broger, H Loetscher, W Lesslauer.   

Abstract

The X-ray crystal structure of the complex of the extracellular domain of the human 55 kd tumor necrosis factor (TNF) receptor with human TNF beta has been determined at 2.85 A resolution. The complex has three receptor molecules bound symmetrically to one TNF beta trimer. The receptor fragment, a very elongated end to end assembly of four similar folding domains, binds in the groove between two adjacent TNF beta subunits. The structure of the complex defines the orientation of the ligand with respect to the cell membrane and provides a model for TNF receptor activation. The novel fold of the TNF receptor structure is likely to be representative of the nerve growth factor (NGF)/TNF receptor family as a whole.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387891     DOI: 10.1016/0092-8674(93)90132-a

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  256 in total

1.  Localization of the gD-binding region of the human herpes simplex virus receptor, HveA.

Authors:  J C Whitbeck; S A Connolly; S H Willis; W Hou; C Krummenacher; M Ponce de Leon; H Lou; I Baribaud; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.

Authors:  M Saraiva; A Alcami
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope.

Authors:  C L Chirinos-Rojas; M W Steward; C D Partidos
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

4.  Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Authors:  J C Whitbeck; C Peng; H Lou; R Xu; S H Willis; M Ponce de Leon; T Peng; A V Nicola; R I Montgomery; M S Warner; A M Soulika; L A Spruce; W T Moore; J D Lambris; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

6.  RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.

Authors:  Christopher A Nelson; Julia T Warren; Michael W-H Wang; Steven L Teitelbaum; Daved H Fremont
Journal:  Structure       Date:  2012-10-02       Impact factor: 5.006

7.  A radioreceptor assay for TNF alpha-binding proteins.

Authors:  V Miller; K D Muirden
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

Authors:  S Mihara; N Suzuki; Y Takeba; K Soejima; S Yamamoto
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.

Authors:  Aruna Bitra; Tzanko Doukov; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

10.  Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.

Authors:  Forough Saki; Zohreh Karamizadeh; Shiva Nasirabadi; Steven Mumm; William H McAlister; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.